First-line CPX-351 Superior to 7 + 3 Induction in Older Patients With High-Risk AML

Slideset - Randomized phase III investigation of CPX-351 vs “7 + 3” induction identified a potential new standard of care for older patients with previously untreated high-risk AML.

Source: Clinical Care Options Leukemia - June 8, 2016 Category: Hematology Source Type: research